Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 459-464

Spandidos Publications

Access to resources Recommend Favorite

Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis

By Howell W.   Rose-Zerilli Matthew  

Familial Cancer, Vol. 5, Iss. 2, 2006-06 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

Serum Evaluation of Interleukin 6 in Ovarian Cancer Patients

By Tempfer C.   Zeisler H.   Sliutz G.   Haeusler G.   Hanzal E.   Kainz C.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

Soluble interleukin-6 receptor to interleukin-6 (sIL6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy

By                    

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 861-864

Spandidos Publications

Access to resources Recommend Favorite

Significance of interleukin-6 (IL-6) in breast cancer (review)

By Knüpfer Heike  

Breast Cancer Research and Treatment, Vol. 102, Iss. 2, 2007-04 ,pp. : 129-135

Springer Publishing Company

Access to resources Recommend Favorite